Based on these findings, we selected 29 SNPs of RANKL, RANK and OPG in the present study to identify whether they were associated with MS-AEs in women receiving adjuvant AI therapy for early stage breast cancer. Here, TNFSF11 is linked to myeloid sarcoma.